Lifecore Biomedical, Inc. De (LFCR) Receivables - Other (2011 - 2025)

Lifecore Biomedical's Receivables - Other history runs 15 years deep, the most recent figure standing at $7.0 million for Q2 2025.

• In Q2 2025, Receivables - Other rose 71.52% year-over-year to $7.0 million; the TTM figure through May 2025 stood at $7.0 million (up 71.52% YoY), while the FY2025 annual figure was $7.0 million, up 71.52% from the prior year.
• Receivables - Other was $7.0 million for Q2 2025 at Lifecore Biomedical, up from $6.1 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $13.9 million in Q1 2022 to a low of $2.9 million in Q4 2023.
• Historically, Receivables - Other has averaged $7.3 million across 5 years, with a median of $6.1 million in 2025.
• The sharpest annual moves came in 2021 and 2023: Receivables - Other jumped 2020.0% in 2021, then sank 67.77% in 2023.
• A 5-year view of Receivables - Other shows it stood at $12.6 million in 2021, then sank by 33.33% to $8.4 million in 2022, then slumped by 65.48% to $2.9 million in 2023, then jumped by 96.48% to $5.7 million in 2024, then gained by 22.48% to $7.0 million in 2025.
• The last three Receivables - Other figures came in at $7.0 million (Q2 2025), $6.1 million (Q1 2025), and $5.7 million (Q4 2024), per Business Quant data.